Tag: Vaccines
J&J COVID-19 Vaccine 66 Percent Effective in Interim Analysis
Efficacy varies by region, with 57 percent efficacy in South Africa and 72 percent efficacy in the United States
U.S. Government to Increase Vaccine Deliveries to States
The United States ranks fifth in the world in the number of doses administered relative to the country's population
COVID-19 Vaccine Likely Safe for Lactating Women
However, Academy of Breastfeeding Medicine calls for lactating women to be included in trials
One-Third of U.S. Adults Likely to Refuse a COVID-19 Vaccine
Blacks, women, and conservatives more hesitant in the United States
Two Billion COVID-19 Vaccine Doses From BioNTech Expected This Year
Company also looking to widen eligibility for the vaccine to include pregnant women, children, and others
Vaccine Rollout Slows as Many Health Care Workers Balk at Shots
In nursing homes and to some degree in hospitals, employees are refusing shots, expressing fears of side effects
11.1 Anaphylaxis Cases/Million Doses of Pfizer-BioNTech COVID-19 Vaccine Reported
Median interval from vaccine receipt to symptom onset was 13 minutes
U.K. Is First Country to Approve Oxford-AstraZeneca COVID-19 Vaccine
Vaccine could become the dominant form of inoculation because at $3 to $4 a dose, it is a fraction of the cost of other vaccines
HD Live! Takes a Look Back at Pandemic’s Progression
David Shulkin, M.D., and Joel Zivot, M.D., discuss handling of pandemic, overcoming vaccine hesitancy
Majority Do Not Support COVID-19 Vaccine Mandates for Adults
Employer mandates deemed more acceptable than state mandates
